Gastroenterology Research and Practice

Upper GI Cancer


Publishing date
23 Nov 2012
Status
Closed
Submission deadline
06 Jul 2012

1Department of Surgery, Städtisches Klinikum Braunschweig, Braunschweig, Germany

2Department of General, Visceral, and Transplantation Surgery, Charitè-University Medicine Berlin, Berlin, Germany

3Department of General, Visceral, and Thoracic Surgery, Klinikum Osnabrueck, Osnabrueck, Germany

4Gastrointestinal Cancer Unit, University of California San Diego Moores Cancer Center, 3855 Health Sciences Drive 0987, La Jolla, CA 92093-0987, USA

This issue is now closed for submissions.
More articles will be published in the near future.

Upper GI Cancer

This issue is now closed for submissions.
More articles will be published in the near future.

Description

Cancers of the upper GI tract require high levels of surgical experience and perioperative management to achieve low complication rates and low mortality. Data show that there is a direct correlation between case load and perioperative mortality particularly for cancers of the esophagus, stomach, liver, bile duct, and pancreas. Short- and long-term survival depends on a variety of factors, which should be considered in this special issue. First of all, the identification of potentially curable patients is crucial. Interdisciplinary conferences discuss the mostly multimodal treatment modalities before onset of treatment. Clinical trials should be included.

Our major interests are all topics that have a correlation with short- and long-term survival. Shortly, diagnostic tools, molecular markers, perioperative chemotherapy or radiation, modern approaches of liver resection and new treatment options for pancreatic cancer.

We invite investigators to submit original articles and reviews of the literature to obtain an actual picture of the topic “upper GI cancer.” Potential topics include, but are not limited to:

  • Modern diagnostic tools as part of the multimodal approach
  • Recent results in multimodal treatment of esophageal or gastric cancer
  • The value of pretherapeutic endoscopic ultrasound in correlation with the effect of neoadjuvant chemotherapy in esophageal and gastric cancer
  • New technical approaches of extended liver surgery and long-term survival
  • Multimodal therapy of pancreatic cancer
  • Complication rate and outcome after surgery
  • Novel molecular markers in pancreatic cancer

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/grp/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:

Gastroenterology Research and Practice
 Journal metrics
Acceptance rate29%
Submission to final decision66 days
Acceptance to publication33 days
CiteScore1.940
Impact Factor1.825
 Submit

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.